{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:48:11Z","timestamp":1791877691619,"version":"4.3.4"},"reference-count":40,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"KAKENHI","doi-asserted-by":"publisher","award":["JP24K10196"],"award-info":[{"award-number":["JP24K10196"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"JSPS Research Fellowships for Young Scientists","award":["JP19J40271"],"award-info":[{"award-number":["JP19J40271"]}]},{"name":"JSPS Research Fellowships for Young Scientists","award":["JP24KJ1983"],"award-info":[{"award-number":["JP24KJ1983"]}]},{"name":"JSPS KAKENHI","award":["JP26460515"],"award-info":[{"award-number":["JP26460515"]}]},{"name":"JSPS KAKENHI","award":["JP26305015"],"award-info":[{"award-number":["JP26305015"]}]},{"name":"JSPS KAKENHI","award":["JP18KK0231"],"award-info":[{"award-number":["JP18KK0231"]}]},{"name":"Ministry of Health, Labor, and Welfare","award":["H26-Iryokiki-Ippan-004"],"award-info":[{"award-number":["H26-Iryokiki-Ippan-004"]}]},{"DOI":"10.13039\/501100013996","name":"Global Health Innovative Technology Fund","doi-asserted-by":"publisher","award":["G2015-210"],"award-info":[{"award-number":["G2015-210"]}],"id":[{"id":"10.13039\/501100013996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013996","name":"Global Health Innovative Technology Fund","doi-asserted-by":"publisher","award":["G2013-105"],"award-info":[{"award-number":["G2013-105"]}],"id":[{"id":"10.13039\/501100013996","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Translational Research Network program"},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["16jm0410004j0004"],"award-info":[{"award-number":["16jm0410004j0004"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Artemisinin (ART) partial resistance has been reported in Southeast Asia and East Africa, but its population-level phenotypic dynamics remain poorly understood. We aimed to evaluate population-level changes in ART susceptibility in Plasmodium falciparum in Northern Uganda using an ex vivo quantitative ring-stage survival assay (qRSA), which assesses parasite survival across 7 serial dihydroartemisinin (DHA) concentrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted repeated cross-sectional surveys in 2014, 2015, 2022, and 2024 in Gulu, Northern Uganda. Ex vivo qRSA was used to compare parasite survival across DHA concentrations before and after the known emergence of ART partial resistance. qRSA resistance level was operationally defined as the highest DHA concentration at which the survival rate (SR) was \u22651%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 323 participants with uncomplicated symptomatic P. falciparum monoinfection were enrolled. qRSA data were obtained from 156 samples. After the known emergence of ART partial resistance, low-level parasite survival persisted toward progressively higher DHA concentrations, resulting in a shift toward higher qRSA resistance levels. All pure kelch13 A675V isolates were classified at the highest qRSA resistance level (700\u2005nM), whereas pure C469Y isolates were distributed across qRSA resistance levels from 87.5 to 700\u2005nM. A similar, but less robust, shift was observed among kelch13 wild-type isolates, accompanied by increased SRs, particularly at 700\u2005nM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings suggest that the population-level shift in ART susceptibility was characterized by persistence of low-level survival toward higher DHA concentrations. Multiconcentration RSA may provide additional insights into early changes in ART susceptibility that are not captured by conventional binary resistance classifications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/infdis\/jiag494","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:33:54Z","timestamp":1790681634000},"source":"Crossref","is-referenced-by-count":0,"title":["Population-Level Shift in Ex Vivo Artemisinin Susceptibility in\n                    <i>Plasmodium falciparum<\/i>\n                    : Comparison of 2014\u20132015 and 2022\u20132024 Surveys in Northern Uganda"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2687-1450","authenticated-orcid":false,"given":"Mie","family":"Ikeda","sequence":"first","affiliation":[{"name":"Department of Tropical Medicine and Parasitology, Faculty of Medicine, Juntendo University , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Balikagala","sequence":"additional","affiliation":[{"name":"Department of Tropical Medicine and Parasitology, Faculty of Medicine, Juntendo University , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Tropical Medicine and Parasitology, Faculty of Medicine, Juntendo University , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Kaneko-Ogawa","sequence":"additional","affiliation":[{"name":"Department of Tropical Medicine and Parasitology, Faculty of Medicine, Juntendo University , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Tropical Medicine and Parasitology, Faculty of Medicine, Juntendo University , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5001-9653","authenticated-orcid":false,"given":"Makoto","family":"Hirai","sequence":"additional","affiliation":[{"name":"Department of Tropical Medicine and Parasitology, Faculty of Medicine, Juntendo University , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osbert T","family":"Katuro","sequence":"additional","affiliation":[{"name":"Med Biotech Laboratories , Kampala ,","place":["Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kubo","sequence":"additional","affiliation":[{"name":"Department of Tropical Medicine and Parasitology, Faculty of Medicine, Juntendo University , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2988-799X","authenticated-orcid":false,"given":"Naoyuki","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Tropical Medicine and Parasitology, Faculty of Medicine, Juntendo University , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Sakurai-Yatsushiro","sequence":"additional","affiliation":[{"name":"International Affairs and Tropical Medicine, School of Medicine, Tokyo Women's Medical University , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8622-8828","authenticated-orcid":false,"given":"Dennis A","family":"Anywar","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Faculty of Medicine, Gulu University , Gulu ,","place":["Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5455-8719","authenticated-orcid":false,"given":"Emmanuel I","family":"Odongo-Aginya","sequence":"additional","affiliation":[{"name":"Department of Microbiology\/Immunology, Faculty of Medicine, Gulu University , Gulu ,","place":["Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Ogwang","sequence":"additional","affiliation":[{"name":"St. Mary's Hospital Lacor , Gulu ,","place":["Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4098-3972","authenticated-orcid":false,"given":"Nirianne M Q","family":"Palacpac","sequence":"additional","affiliation":[{"name":"Department of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3000-2045","authenticated-orcid":false,"given":"Toshihiro","family":"Horii","sequence":"additional","affiliation":[{"name":"Department of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8180-2344","authenticated-orcid":false,"given":"Toshihiro","family":"Mita","sequence":"additional","affiliation":[{"name":"Department of Tropical Medicine and Parasitology, Faculty of Medicine, Juntendo University , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"2026101303162978200_jiag494-B1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(12)60034-8","article-title":"Global malaria mortality between 1980 and 2010: a systematic analysis","volume":"379","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"2026101303162978200_jiag494-B2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0140-6736(19)31097-9","article-title":"Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000-17: a spatial and temporal modelling study","volume":"394","author":"Weiss","year":"2019","journal-title":"Lancet"},{"key":"2026101303162978200_jiag494-B3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N Engl J Med"},{"key":"2026101303162978200_jiag494-B4","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/S0140-6736(12)60484-X","article-title":"Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study","volume":"379","author":"Phyo","year":"2012","journal-title":"Lancet"},{"key":"2026101303162978200_jiag494-B5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of artemisinin-resistant malaria in Africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"N Engl J Med"},{"key":"2026101303162978200_jiag494-B6","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","article-title":"Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study","volume":"21","author":"Uwimana","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2026101303162978200_jiag494-B7","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2210956","article-title":"Increasing prevalence of artemisinin-resistant HRP2-negative malaria in Eritrea","volume":"389","author":"Mihreteab","year":"2023","journal-title":"N Engl J Med"},{"key":"2026101303162978200_jiag494-B8","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S1473-3099(24)00362-1","article-title":"Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance","volume":"24","author":"Ishengoma","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2026101303162978200_jiag494-B9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N Engl J Med"},{"key":"2026101303162978200_jiag494-B10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12936-017-1731-1","article-title":"Malaria parasite clearance","volume":"16","author":"White","year":"2017","journal-title":"Malar J"},{"key":"2026101303162978200_jiag494-B11","author":"WHO"},{"key":"2026101303162978200_jiag494-B12","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","article-title":"Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies","volume":"13","author":"Witkowski","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"2026101303162978200_jiag494-B13","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00172-17","article-title":"Plasmodium falciparum K13 mutations differentially impact ozonide susceptibility and parasite fitness in vitro","volume":"8","author":"Straimer","year":"2017","journal-title":"mBio"},{"key":"2026101303162978200_jiag494-B14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng.3189","article-title":"Genetic architecture of artemisinin-resistant Plasmodium falciparum","volume":"47","author":"Miotto","year":"2015","journal-title":"Nat Genet"},{"key":"2026101303162978200_jiag494-B15","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.08714","article-title":"Genomic epidemiology of artemisinin resistant malaria","volume":"5","author":"MalariaGEN Plasmodium falciparum Community Project","year":"2016","journal-title":"Elife"},{"key":"2026101303162978200_jiag494-B16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/infdis\/jiaa687","article-title":"Changing prevalence of potential mediators of aminoquinoline, antifolate, and artemisinin resistance across Uganda","volume":"223","author":"Asua","year":"2021","journal-title":"J Infect Dis"},{"key":"2026101303162978200_jiag494-B17","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa2211803","article-title":"Evolution of partial resistance to artemisinins in malaria parasites in Uganda","volume":"389","author":"Conrad","year":"2023","journal-title":"N Engl J Med"},{"key":"2026101303162978200_jiag494-B18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1473-3099(25)00407-4","article-title":"Efficacies of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trial","volume":"26","author":"Kamya","year":"2026","journal-title":"Lancet Infect Dis"},{"key":"2026101303162978200_jiag494-B19","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1016\/S1473-3099(26)00132-5","article-title":"Artemisinin partial resistance at a crossroads: evidence for continental variation in Plasmodium falciparum clearance phenotypes","volume":"26","author":"Hosangadi","year":"2026","journal-title":"Lancet Infect Dis"},{"key":"2026101303162978200_jiag494-B20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"2026101303162978200_jiag494-B21","volume-title":"Ring-stage Survival Assays (RSA) to evaluate the in-vitro and ex-vivo susceptibility of Plasmodium falciparum to artemisinins","author":"Witkowski","year":"2014"},{"key":"2026101303162978200_jiag494-B22","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3201\/eid2404.170141","article-title":"Artemisinin-resistant Plasmodium falciparum with high survival rates, Uganda, 2014\u20132016","volume":"24","author":"Ikeda","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2026101303162978200_jiag494-B23","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"2026101303162978200_jiag494-B24","doi-asserted-by":"publisher","author":"Bower-Lepts","DOI":"10.64898\/2026.05.05.722990"},{"key":"2026101303162978200_jiag494-B25","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1038\/s41591-026-04590-5","article-title":"Emergence and spread of Plasmodium falciparum PX1 polymorphisms associated with decreased susceptibility to antimalarials in Uganda","volume":"32","author":"Niar\u00e9","year":"2026","journal-title":"Nat Med"},{"key":"2026101303162978200_jiag494-B26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1073\/pnas.1006113108","article-title":"Intrahost modeling of artemisinin resistance in Plasmodium falciparum","volume":"108","author":"Saralamba","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026101303162978200_jiag494-B27","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1073\/pnas.1615875114","article-title":"Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort","volume":"114","author":"Ataide","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026101303162978200_jiag494-B28","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/cid\/ciac944","article-title":"The impact of sequestration on artemisinin-induced parasite clearance in Plasmodium falciparum malaria in Africa","volume":"76","author":"Fukuda","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026101303162978200_jiag494-B29","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"key":"2026101303162978200_jiag494-B30","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.66277","article-title":"Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness","volume":"10","author":"Stokes","year":"2021","journal-title":"Elife"},{"key":"2026101303162978200_jiag494-B31","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMc2117480","article-title":"Evidence of artemisinin-resistant malaria in Africa","volume":"386","author":"Stokes","year":"2022","journal-title":"N Engl J Med"},{"key":"2026101303162978200_jiag494-B32","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1038\/s41467-022-33873-x","article-title":"Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda","volume":"13","author":"Tumwebaze","year":"2022","journal-title":"Nat Commun"},{"key":"2026101303162978200_jiag494-B33","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1038\/s41467-025-62810-x","article-title":"Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019\u20132024","volume":"16","author":"Okitwi","year":"2025","journal-title":"Nat Commun"},{"key":"2026101303162978200_jiag494-B34","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","article-title":"Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number","volume":"364","author":"Price","year":"2004","journal-title":"Lancet"},{"key":"2026101303162978200_jiag494-B35","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1126\/science.1098876","article-title":"Intercontinental spread of pyrimethamine-resistant malaria","volume":"305","author":"Roper","year":"2004","journal-title":"Science"},{"key":"2026101303162978200_jiag494-B36","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/656476","article-title":"Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure","volume":"202","author":"Teuscher","year":"2010","journal-title":"J Infect Dis"},{"key":"2026101303162978200_jiag494-B37","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1128\/AAC.01636-09","article-title":"Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism","volume":"54","author":"Witkowski","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2026101303162978200_jiag494-B38","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00605-18","article-title":"Fitness costs and the rapid spread of kelch13-C580Y substitutions conferring artemisinin resistance","volume":"62","author":"Nair","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2026101303162978200_jiag494-B39","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1473-3099(22)00697-1","article-title":"Malaria outbreak in Laos driven by a selective sweep for Plasmodium falciparum kelch13 R539T mutants: a genetic epidemiology analysis","volume":"23","author":"Wasakul","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2026101303162978200_jiag494-B40","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/jac\/dkv199","article-title":"Fitness of artemisinin-resistant Plasmodium falciparum in vitro","volume":"70","author":"Hott","year":"2015","journal-title":"J Antimicrob Chemother"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiag494\/71497897\/jiag494.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiag494\/71497897\/jiag494.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:16:38Z","timestamp":1791875798000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/advance-article\/doi\/10.1093\/infdis\/jiag494\/8851226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":40,"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiag494","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"jiag494"}}